John Patrick Oroho, Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC to Speak at Knowledge Congress’ Live Webcast
New York, NY, April 13, 2013 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that John Patrick Oroho, Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, will speak at a 2-hour webcast entitled “Sunshine Act: The Final Rule Live Webcast.” This event is scheduled for June 24, 2013 from 12pm-2pm (ET).
About John Patrick Oroho
John Patrick Oroho is the Executive Vice President and Chief Strategy Officer of Porzio Life Sciences, LLC, meets regularly with companies to identify sales and marketing issues and to propose solutions that streamline their understanding of acceptable practices and conduct in meeting compliance requirements of all 50 states and the District of Columbia.
Mr. Oroho is also a principal of the law firm, Porzio, Bromberg & Newman P.C., and practices in the Life Sciences Compliance, Commercialization and Regulatory Counseling department. He concentrates his law practice in regulatory compliance with respect to the Prescription Drug Marketing Act (PDMA), Anti-kickback statute, False Claims Act, and Medicare and Medicaid fraud and abuse.
Mr. Oroho previously served as Senior Vice President and General Counsel for the PDMA Alliance, a national trade association focused on sample distribution and pharmaceutical marketing and sales compliance.
Mr. Oroho has an extensive life sceinces regulatory and compliance background. He spent three years as General Counsel for Integrated Pharma Technologies and Computer Systems Services & Consulting, Inc.
Mr. Oroho received a J.D. from the University of Notre Dame School of Law in 1985 and a B.S. from the United States Merchant Marine Academy, where he graduated with honors in 1978.
About Porzio Life Sciences
Porzio Life Sciences, LLC (PorzioLS) provides the life science industry with Internet-based products enabling companies to comply with marketing and sales federal and state laws and regulations, as well as, distribution, licensing, sampling and a growing body of state pharmaceutical compliance requirements. PorzioLS provides compliance tools and customized services, related to the PDMA, anti-kickback statutes, aggregate spend reporting, OIG and CMS guidances, False Claims Act and FDA regulations, such as the Porzio Compliance Digest and Porzio AggregateSpendID, a best in class aggregate spend system capable of handling state and federal transparency reporting, in addition to sample transparency reporting to FDA and Vermont. These compliance tools and customized services facilitate companies’ compliance with federal and state marketing and sales regulations, which has propelled PorzioLS into an industry leader in life science marketing and sales compliance.
To know more about John Patrick Oroho and Porzio Life Sciences please visit: www.porziols.com
Event Synopsis:
Compliance for healthcare industry will be completely challenging as the Centers for Medicare & Medicaid Services (CMS) implements Final Rule of Section 6002 of the Affordable Care Act, commonly known as “Sunshine Act.” The provision aims to increase transparency of financial relationships between the industry, healthcare providers and patients.
More specifically, the Sunshine Act requires drug, biological and medical supply manufacturers (including group purchasing organizations (GPOs)) to report, in significant detail, payments made to physicians and other medical institutions to the Federal Government on an annual basis. It also the affected organizations, to report certain ownership or investment interest held by physicians and their immediate family members. Furthermore, the information that will be disclosed will be posted on a public website.
Group Purchasing Organizations, Device Manufacturers, Biotech Companies and Pharmaceutical Companies must have a complete understanding of the Final Rule to avoid penalties and fines.
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries. Its mission is to produce unbiased, objective, and educational live webcasts that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format.
The organization brings together the world's leading authorities and industry participants through informative two-hour webcasts to study the impact of changes and emerging trends. Hear from leading government officials/regulators, key thought leaders, and industry experts objectively analyze the latest trends and issues and their impact on industries. For further details, please visit the organization’s website: www.knowledgecongress.org
About John Patrick Oroho
John Patrick Oroho is the Executive Vice President and Chief Strategy Officer of Porzio Life Sciences, LLC, meets regularly with companies to identify sales and marketing issues and to propose solutions that streamline their understanding of acceptable practices and conduct in meeting compliance requirements of all 50 states and the District of Columbia.
Mr. Oroho is also a principal of the law firm, Porzio, Bromberg & Newman P.C., and practices in the Life Sciences Compliance, Commercialization and Regulatory Counseling department. He concentrates his law practice in regulatory compliance with respect to the Prescription Drug Marketing Act (PDMA), Anti-kickback statute, False Claims Act, and Medicare and Medicaid fraud and abuse.
Mr. Oroho previously served as Senior Vice President and General Counsel for the PDMA Alliance, a national trade association focused on sample distribution and pharmaceutical marketing and sales compliance.
Mr. Oroho has an extensive life sceinces regulatory and compliance background. He spent three years as General Counsel for Integrated Pharma Technologies and Computer Systems Services & Consulting, Inc.
Mr. Oroho received a J.D. from the University of Notre Dame School of Law in 1985 and a B.S. from the United States Merchant Marine Academy, where he graduated with honors in 1978.
About Porzio Life Sciences
Porzio Life Sciences, LLC (PorzioLS) provides the life science industry with Internet-based products enabling companies to comply with marketing and sales federal and state laws and regulations, as well as, distribution, licensing, sampling and a growing body of state pharmaceutical compliance requirements. PorzioLS provides compliance tools and customized services, related to the PDMA, anti-kickback statutes, aggregate spend reporting, OIG and CMS guidances, False Claims Act and FDA regulations, such as the Porzio Compliance Digest and Porzio AggregateSpendID, a best in class aggregate spend system capable of handling state and federal transparency reporting, in addition to sample transparency reporting to FDA and Vermont. These compliance tools and customized services facilitate companies’ compliance with federal and state marketing and sales regulations, which has propelled PorzioLS into an industry leader in life science marketing and sales compliance.
To know more about John Patrick Oroho and Porzio Life Sciences please visit: www.porziols.com
Event Synopsis:
Compliance for healthcare industry will be completely challenging as the Centers for Medicare & Medicaid Services (CMS) implements Final Rule of Section 6002 of the Affordable Care Act, commonly known as “Sunshine Act.” The provision aims to increase transparency of financial relationships between the industry, healthcare providers and patients.
More specifically, the Sunshine Act requires drug, biological and medical supply manufacturers (including group purchasing organizations (GPOs)) to report, in significant detail, payments made to physicians and other medical institutions to the Federal Government on an annual basis. It also the affected organizations, to report certain ownership or investment interest held by physicians and their immediate family members. Furthermore, the information that will be disclosed will be posted on a public website.
Group Purchasing Organizations, Device Manufacturers, Biotech Companies and Pharmaceutical Companies must have a complete understanding of the Final Rule to avoid penalties and fines.
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries. Its mission is to produce unbiased, objective, and educational live webcasts that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format.
The organization brings together the world's leading authorities and industry participants through informative two-hour webcasts to study the impact of changes and emerging trends. Hear from leading government officials/regulators, key thought leaders, and industry experts objectively analyze the latest trends and issues and their impact on industries. For further details, please visit the organization’s website: www.knowledgecongress.org
Contact
The Knowledge Congress
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories